<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:sbol="http://sbols.org/v2#" xmlns:ns0="http://www.w3.org/ns/prov#" xmlns:ns1="http://purl.org/dc/terms/" xmlns:ns2="http://wiki.synbiohub.org/wiki/Terms/synbiohub#" xmlns:ns3="http://purl.org/dc/elements/1.1/" xmlns:ns4="http://purl.obolibrary.org/obo/">
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00302_1_comp/1">
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00302_1_sequence/1"/>
    <sbol:displayId>sb7b00302_1_comp</sbol:displayId>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00302"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00302_1_comp"/>
    <sbol:version>1</sbol:version>
  </sbol:ComponentDefinition>
  <sbol:Collection rdf:about="http://examples.org/Collection/sb7b00302/1">
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00302_2_sequence/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00302_3_comp/1"/>
    <ns1:isPartOf rdf:resource="http://pubs.acs.org/journal/asbcd6"/>
    <ns1:dateAccepted>2018-05-07</ns1:dateAccepted>
    <ns2:topLevel rdf:resource="https://synbioks.org/public/ACS/sb7b00302/1"/>
    <sbol:version>1</sbol:version>
    <ns1:dateCopyrighted>2018</ns1:dateCopyrighted>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00302_3_sequence/1"/>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00302_2_comp/1"/>
    <ns1:dateSubmitted>2017-08-21</ns1:dateSubmitted>
    <ns3:type>research-article</ns3:type>
    <sbol:member rdf:resource="http://examples.org/ComponentDefinition/sb7b00302_1_comp/1"/>
    <ns2:ownedBy rdf:resource="https://synbioks.org/user/myers"/>
    <ns3:subject>protein design</ns3:subject>
    <ns3:publisher>American Chemical
Society</ns3:publisher>
    <ns1:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <sbol:displayId>sb7b00302</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Collection/sb7b00302"/>
    <ns1:abstract>Destabilizing domains (DDs) are genetic tags that conditionally control the level of abundance of proteins-of-interest (POI) with specific stabilizing small-molecule drugs, rapidly and reversibly, in a wide variety of organisms. The amount of the DD-tagged fusion protein directly impacts its molecular function. Hence, it is important that the background levels be tightly regulated in the absence of any drug. This is especially true for classes of proteins that function at extremely low levels, such as lethality genes involved in tissue development and certain transcriptional activator proteins. Here, we establish the uninduced background and induction levels for two widely used DDs (FKBP and DHFR) by developing an accurate quantification method. We show that both DDs exhibit functional background levels in the absence of a drug, but each to a different degree. To overcome this limitation, we systematically test a double architecture for these DDs (DD-POI-DD) that completely suppresses the protein&#8217;s function in an uninduced state, while allowing tunable functional levels upon adding a drug. As an example, we generate a drug-stabilizable Gal4 transcriptional activator with extremely low background levels. We show that this functions in vivo in the widely used Gal4-UAS bipartite expression system in Drosophila melanogaster. By regulating a cell death gene, we demonstrate that only the low background double architecture enables tight regulation of the lethal phenotype in vivo. These improved tools will enable applications requiring exceptionally tight control of protein function in living cells and organisms.</ns1:abstract>
    <ns3:creator>Mark Isalan</ns3:creator>
    <ns1:rightsHolder>American Chemical Society</ns1:rightsHolder>
    <sbol:member rdf:resource="http://examples.org/Sequence/sb7b00302_1_sequence/1"/>
    <ns1:created>2018-05-07</ns1:created>
    <ns1:references>Zeidler, M. P., Tan, C., Bellaiche, Y., Cherry, S., Hader, S., Gayko, U., Perrimon, N. Temperature-sensitive control of protein activity by conditionally splicing inteins Nat. Biotechnol. 2004. 22:871-876.</ns1:references>
    <ns4:OBI_0001617>29733646</ns4:OBI_0001617>
    <ns4:OBI_0002110>10.1021/acssynbio.7b00302</ns4:OBI_0002110>
    <ns1:description>Destabilizing domains (DDs) are genetic tags that conditionally control the level of abundance of proteins-of-interest (POI) with specific stabilizing small-molecule drugs, rapidly and reversibly, in a wide variety of organisms. The amount of the DD-tagged fusion protein directly impacts its molecular function. Hence, it is important that the background levels be tightly regulated in the absence of any drug. This is especially true for classes of proteins that function at extremely low levels, such as lethality genes involved in tissue development and certain transcriptional activator proteins. Here, we establish the uninduced background and induction levels for two widely used DDs (FKBP and DHFR) by developing an accurate quantification method. We show that both DDs exhibit functional background levels in the absence of a drug, but each to a different degree. To overcome this limitation, we systematically test a double architecture for these DDs (DD-POI-DD) that completely suppresses the protein&#8217;s function in an uninduced state, while allowing tunable functional levels upon adding a drug. As an example, we generate a drug-stabilizable Gal4 transcriptional activator with extremely low background levels. We show that this functions in vivo in the widely used Gal4-UAS bipartite expression system in Drosophila melanogaster. By regulating a cell death gene, we demonstrate that only the low background double architecture enables tight regulation of the lethal phenotype in vivo. These improved tools will enable applications requiring exceptionally tight control of protein function in living cells and organisms.</ns1:description>
  </sbol:Collection>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00302_2_comp/1">
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <sbol:displayId>sb7b00302_2_comp</sbol:displayId>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00302"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00302_2_sequence/1"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00302_2_comp"/>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:version>1</sbol:version>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00302_3_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00302_3_sequence"/>
    <sbol:elements>atgatcagtctgattgcggcgttagcggtagatcacgttatcggcatggaaaacgccatgccgtggagcctgcctgccgatctcgcctggtttaaacgcaacaccttaaataaacccgtgattatgggccgccatacctgggaatcaatcggtcgtccgttgccaggacgcaaaaacattatcctcagcagtcaaccgagtacggacgatcgcgtaacgtgggtgaagtcggcggatgaagccatcgcggcgtgtggtgacgtaccagaaatcatggtgattggcggcggtcgcgtttatgagcagttcttgccaaaagcgcaaaaactgtatctgacgcatatcgacgcagaagtgggaggcgacacccatttcccggattacgagccggatgactggggatcggtattcagcgaattccacgatgctgatgcgcagaactctcacagctattgctttgtgattctggggcggcgaatgaagctactgtcttctatcgaacaagcatgcgatatttgccgacttaaaaagctcaagtgctccaaagaaaaaccgaagtgcgccaagtgtctgaagaacaactgggagtgtcgctactctcccaaaaccaaaaggtctccgctgactagggcacatctgacagaagtggaatcaaggctagaaagactggaacagctatttctactgatttttcctcgagaagaccttgacatgattttgaaaatggattctttacaggatataaaagcattgttaacaggattatttgtacaagataatgtgaataaagatgccgtcacagatagattggcttcagtggagactgatatgcctctaacattgagacagcatagaataagtgcgacatcatcatcggaagagagtagtaacaaaggtcaaagacagttgactgtatcgccggaattcccggggatctgggcccccccgaccgatgtcagcctgggggacgagctccacttagacggcgaggacgtggcgatggcgcatgccgacgcgctagacgatttcgatctggacatgttgggggacggggattccccgggtccgggatttaccccccacgactccgccccctacggcgctctggatatggccgacttcgagtttgagcagatgtttaccgatgcccttggaattgacgagtacggtgggatgatcagtctgattgcggcgttagcggtagatcacgttatcggcatggaaaacgccatgccgtggagcctgcctgccgatctcgcctggtttaaacgcaacaccttaaataaacccgtgattatgggccgccatacctgggaatcaatcggtcgtccgttgccaggacgcaaaaacattatcctcagcagtcaaccgagtacggacgatcgcgtaacgtgggtgaagtcggcggatgaagccatcgcggcgtgtggtgacgtaccagaaatcatggtgattggcggcggtcgcgtttatgagcagttcttgccaaaagcgcaaaaactgtatctgacgcatatcgacgcagaagtgggaggcgacacccatttcccggattacgagccggatgactggggatcggtattcagcgaattccacgatgctgatgcgcagaactctcacagctattgctttgtgattctggggcggcga</sbol:elements>
    <sbol:displayId>sb7b00302_3_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
  </sbol:Sequence>
  <sbol:ComponentDefinition rdf:about="http://examples.org/ComponentDefinition/sb7b00302_3_comp/1">
    <sbol:version>1</sbol:version>
    <sbol:type rdf:resource="http://www.biopax.org/release/biopax-level3.owl#DnaRegion"/>
    <sbol:displayId>sb7b00302_3_comp</sbol:displayId>
    <sbol:persistentIdentity rdf:resource="http://examples.org/ComponentDefinition/sb7b00302_3_comp"/>
    <ns0:wasGeneratedBy rdf:resource="https://synbiohub.org/public/sbksactivities/ACS_Synbio_Generation/1"/>
    <ns0:wasDerivedFrom rdf:resource="https://doi.org/10.1021/acssynbio.7b00302"/>
    <sbol:sequence rdf:resource="http://examples.org/Sequence/sb7b00302_3_sequence/1"/>
  </sbol:ComponentDefinition>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00302_2_sequence/1">
    <sbol:version>1</sbol:version>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:displayId>sb7b00302_2_sequence</sbol:displayId>
    <sbol:elements>acaagataatgtgaataaagatgccgtcacagatagattggcttcagtggagactgatatgcctctaacattgagacagcatagaataagtgcgacatcatcatcggaagagagtagtaacaaaggtcaaagacagttgactgtatcgccggaattcccggggatctgggcccccccgaccgatgtcagcctgggggacgagctccacttagacggcgaggacgtggcgatggcgcatgccgacgcgctagacgatttcgatctggacatgttgggggacggggattccccgggtccgggatttaccccccacgactccgccccctacggcgctctggatatggccgacttcgagtttgagcagatgtttaccgatgcccttggaattgacgagtacggtggg</sbol:elements>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00302_2_sequence"/>
  </sbol:Sequence>
  <sbol:Sequence rdf:about="http://examples.org/Sequence/sb7b00302_1_sequence/1">
    <sbol:displayId>sb7b00302_1_sequence</sbol:displayId>
    <sbol:encoding rdf:resource="http://www.chem.qmul.ac.uk/iubmb/misc/naseq.html"/>
    <sbol:persistentIdentity rdf:resource="http://examples.org/Sequence/sb7b00302_1_sequence"/>
    <sbol:elements>atgatcagtctgattgcggcgttagcggtagatcacgttatcggcatggaaaacgccatgccgtggagcctgcctgccgatctcgcctggtttaaacgcaacaccttaaataaacccgtgattatgggccgccatacctgggaatcaatcggtcgtccgttgccaggacgcaaaaacattatcctcagcagtcaaccgagtacggacgatcgcgtaacgtgggtgaagtcggcggatgaagccatcgcggcgtgtggtgacgtaccagaaatcatggtgattggcggcggtcgcgtttatgagcagttcttgccaaaagcgcaaaaactgtatctgacgcatatcgacgcagaagtgggaggcgacacccatttcccggattacgagccggatgactggggatcggtattcagcgaattccacgatgctgatgcgcagaactctcacagctattgctttgtgattctggggcggcgaatgaagctactgtcttctatcgaacaagcatgcgatatttgccgacttaaaaagctcaagtgctccaaagaaaaaccgaagtgcgccaagtgtctgaagaacaactgggagtgtcgctactctcccaaaaccaaaaggtctccgctgactagggcacatctgacagaagtggaatcaaggctagaaagactggaacagctatttctactgatttttcctcgagaagaccttgacatgattttgaaaatggattctttacaggatataaaagcattgttaacaggattatttgt</sbol:elements>
    <sbol:version>1</sbol:version>
  </sbol:Sequence>
</rdf:RDF>
